Everyday Health on MSN
9 calcium supplements dietitians swear by
Discover the best calcium supplements, according to dietitians. From capsules, powders, and gummies, find the best choice for ...
Creators Syndicate on MSN
Just a few devilish details
You can't rely on your doctor to remember to tell you every little detail before an operation or procedure. I once went in ...
A 2026 informational overview of ViriFlow's hard water mineral theory, saw palmetto and iodine-rich seaweed blend research, ...
Pfizer (PFE) announced on Thursday that its cancer drug regimen, Talzenna plus Xtandi, met the primary endpoint in a Phase 3 trial for a new indication in prostate cancer. The Phase 3 TALAPRO-3 study ...
Primary endpoint met in Phase 3 TALAPRO-3 study demonstrating a statistically significant and clinically meaningful reduction in risk of disease progression or death in HRR gene-mutated metastatic ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) ...
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with ...
Talazoparib plus enzalutamide met the primary endpoint in TALAPRO-2, lowering radiographic progression or death risk by 37% versus enzalutamide, with median rPFS not reached. Efficacy signals extended ...
A partitioned-survival lifetime model (2025 USD) compared ADT alone with seven intensification strategies across PFS, post-progression, and death, using published survival curves and literature-based ...
When you have prostate cancer, dating can feel more like a minefield than a walk in the park. What’s the right time to tell a potential partner about your condition? And how should you bring it up? It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results